Open Insider Trading Activity for Rapport Therapeutics, Inc. Chief Development Officer Yeleswaram Krishnaswamy
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction RAPP | 2026-04-21 | 2026-04-17 | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | 1 | 20,225 | $39.99 | $808,797.75 | 7.58% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction RAPP | 2026-04-14 | 2026-04-14 | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | 3 | 19,865 | $35.03 | $695,806.05 | 2.34% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction RAPP | 2026-04-09 | 2026-04-08 | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | 1 | 360 | $34.90 | $12,564.00 | 0.13% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction RAPP | 2026-03-26 | 2026-03-25 | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | 1 | 10,115 | $29.99 | $303,348.85 | 3.41% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RAPP | 2026-01-05 | 2025-12-31 | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | 1 | 2,840 | $30.05 | $85,342.00 | 0.95% | View Filing |